Advances In Obesity Management

Approximately two thirds of adults and one -fifth of children in the United States are either overweight or obese, placing them at high absolute risk for mortality from numerous chronic diseases. The increase in obesity has been dramatic. In 2008, only 1 state had an obesity rate less than 20%, compared with 1994, when no state had a rate greater than 19%. The risk factors and causes of obesity are diverse and include a wide range of genetic, metabolic, behavioral, cultural, and environmental factors. Thus, the health, economic, and social consequences of obesity are potentially devastating for the United States.
The Advances In Obesity Management curriculum is a series of evidence-based continuing medical education activities designed to educate endocrinologists, OB/GYNs, primary care physicians, and other clinicians involved in the care of patients with obesity on the current evidence and practices in the management of obesity, including the mechanism of action, efficacy, safety, and tolerability of emerging pharmacotherapies for the treatment of obesity. With up-to-date information and expert insight, clinicians will be better able to positively affect patient outcomes.

Slide and Audio Presentations

Strategies to Combat Obesity: The Role of Appetite Regulation and Impulse Control CME
Explore the physiology of weight gain, principles of food addiction, and regulation of appetite, including the benefits and limitations of current weight loss approaches. This CME activity is based on the slides and lectures presented by Donna Ryan, MD; David M. Kendall, MD; John Blundell, PhD, FBPsS; and Ken Fujioka, MD, at the symposium "Strategies to Combat Obesity: The Role of Appetite Regulation and Impulse Control," on October 9, 2010, at the Hilton Bayfront Hotel, San Diego, California.
The Obesity Epidemic! Exploring Emerging Strategies for Weight Control and Risk Reduction
Review the latest data on risk assessment and evidence of the health benefits of weight loss, as well as emerging therapeutic options designed to control weight. This CME/CNE/CPE activity is based on slides and lectures presented by George Bray, MD; Robert Kushner, MD; Donna Ryan, MD; and Louis Aronne, MD, at the symposium "The Obesity Epidemic! Exploring Emerging Strategies for Weight Control and Risk Reduction" on October 26, 2009, at the Marriott Wardman Park Hotel in Washington, DC.

Obesity as a CNS Disorder: Targeting the Neuronal Circuitry of Weight Loss CME
Robert F. Kushner, MD, explores the rationale, efficacy, safety, and tolerability of new targeted pharmacotherapies for obesity.

The Evolution of Obesity Therapies: New Applications for Existing Drugs CME
This video roundtable discussion with experts provides practical insights on the efficacy, safety, and tolerability data of current approaches to obesity management and emerging pharmacotherapy options for obesity. The epidemiology and causes of obesity, including current strategies for preventing and treating obesity, also will be discussed.

Obesity and Cardiometabolic Risk Factors: The Loaded Gun CME
Ken Fujioka, MD, reviews clinical evidence on the connection between obesity and comorbid conditions, including the effect of weight loss on diabetes, CVD, and renal disease risk.

Steering Committee Chair

Ken Fujioka, MD
Director, Nutrition and Metabolic Research Center, Scripps Clinic, La Jolla, California

Steering Committee

Caroline Apovian, MD
Associate Professor of Medicine and Pediatrics, Boston University School of Medicine, Boston, Massachusetts; Director, Nutrition and Weight Management, Boston Medical Center, Boston, Massachusetts
James Hill, PhD
Professor, University of Colorado School of Medicine, Aurora, Colorado; Director, Center for Human Nutrition, University of Colorado - Denver
Louis Aronne, MD
Clinical Professor of Medicine, Weill Cornell Medical College - New York Presbyterian Hospital, New York, NY; Director, Comprehensive Weight Control Program, Louis J. Aronne, MD (private practice), New York, NY
Vivian M. Dickerson, MD
Women's Healthcare Consultants, Orange, California

	Do you prescribe weight loss medications or medications that are approved for other diseases to primarily promote weight loss?
		Yes
		No